<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>Kickoff Feedback</title>
  <link rel="self" href="https://www.poctrn.org/ja/c/message_boards/find_thread?p_l_id=864599&amp;threadId=894189" />
  <subtitle>Kickoff Feedback</subtitle>
  <id>https://www.poctrn.org/ja/c/message_boards/find_thread?p_l_id=864599&amp;threadId=894189</id>
  <updated>2026-06-11T06:37:53Z</updated>
  <dc:date>2026-06-11T06:37:53Z</dc:date>
  <entry>
    <title>Kickoff Feedback</title>
    <link rel="alternate" href="https://www.poctrn.org/ja/c/message_boards/find_message?p_l_id=864599&amp;messageId=894188" />
    <author>
      <name>Marshall Collins</name>
    </author>
    <id>https://www.poctrn.org/ja/c/message_boards/find_message?p_l_id=864599&amp;messageId=894188</id>
    <updated>2019-05-07T09:49:03Z</updated>
    <published>2019-05-07T09:48:34Z</published>
    <summary type="html">- additional data to support claims (early diagnosis would be beneficial, what are these?) &lt;br /&gt;    - are there studies to confirm this?&lt;br /&gt;- Current presentation is a little too abstract, but for the value prop you&amp;#39;ll want to provide data with progression of patient diagnosed early/late&lt;br /&gt;- at what point does therapy start? 5 months is too early for behavior&lt;br /&gt;- value props should be measurable, so setting up problem with data in value prop allow you to have a hard number to measure&lt;br /&gt;- no data showing how tech of eye-tracking is effective. Even in a short pitch, it&amp;#39;s good to have that data visible&lt;br /&gt;- short pitch, however long slides with text to read. Should focus on what you&amp;#39;re saying. &lt;br /&gt;- how early can this be detected through any means? Average age of diagnosis, but what is current flow? Is this based on an assumption and then wait 3 years?&lt;br /&gt;- what&amp;#39;s customer acquisition cost? This would affect overall self-assessment&lt;br /&gt;- business protection is going to be unique access to data sets, and relationships with key organizations. This is more broad than any IP&lt;br /&gt;- don&amp;#39;t know cost, reimbursement, it&amp;#39;s screening not diagnostic. This is for pitching to angel investors, and currently the estimates are inflated&lt;br /&gt;- value prop is very strong, HIC assessment is well done to recognize it&amp;#39;s early&lt;br /&gt;- start to think about giving &amp;#34;us&amp;#34; (wildcard) permission to believe that this technology, or functionality will be enough to move forward&lt;br /&gt;    - don&amp;#39;t need to see the evidence, just identify what you can show&lt;br /&gt;- subjective diagnostis to objective diagnosis is easy to understand&lt;br /&gt;- using off the shelf technology is good and bad- may need to flesh out more about what works, why it works etc&lt;br /&gt;- what are the numbers to support why this would be compelling?&lt;br /&gt;- compelling need is clear, however there&amp;#39;s no compelling story yet- show what people are doing today and the flow through pediatrician, where does your solution fit in?&lt;br /&gt;- how often would this be used? Once by every clinician, multiple, mixed? Need to show one image to represent&lt;br /&gt;- evidence standpoint: can it be used as monitoring of therapy? Unclear that this has longitudinal value which affects revenue models&lt;br /&gt;- how long for this? once for 30 seconds, or over months?</summary>
    <dc:creator>Marshall Collins</dc:creator>
    <dc:date>2019-05-07T09:48:34Z</dc:date>
  </entry>
</feed>
